Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations

Since COVID-19 risk of reinfection is of great concern, the safety and efficacy of the mRNA-based vaccines in previously infected populations should be assessed. We studied 78 individuals previously infected with SARS-CoV-19, who received a single dose of BNT162b2 mRNA COVID-19 vaccine, and 1:2 rati...

Descripción completa

Detalles Bibliográficos
Autores principales: Efrati, Shai, Catalogna, Merav, Abu Hamad, Ramzia, Hadanny, Amir, Bar-Chaim, Adina, Benveniste-Levkovitz, Patricia, Levtzion-korach, Osnat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367980/
https://www.ncbi.nlm.nih.gov/pubmed/34400714
http://dx.doi.org/10.1038/s41598-021-96129-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367980/
https://www.ncbi.nlm.nih.gov/pubmed/34400714
http://dx.doi.org/10.1038/s41598-021-96129-6

Ejemplares similares